NIH Launches Clinical Trial of Three mRNA HIV Vaccines
3-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID)…
NIAID Newsroom
Researchers Document Third Known Case of HIV Remission Involving Stem Cell Transplant
2-15-2022Cross-posted from NIAID NewsroomWoman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood stem cell transplant to treat …
Statement—NIH Celebrates FDA Approval of Long-Acting Injectable Drug for HIV Prevention
12-21-2021Cross-posted from NIAID NewsroomApproval Marks Pivotal Expansion of HIV Prevention Options in the United StatesYesterday the U.S. Food and Drug Administration a…
Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in …
Too Many People with HIV Fail to Achieve Durable Viral Suppression
11-30-2021NIH-Funded Study Estimates Global Progress Toward UNAIDS GoalCross-posted from NIAID NewsroomAmong people with HIV worldwide who are receiving antiretroviral th…
NIH Experts Call for Accelerated Research to Address Concurrent HIV and COVID-19 Pandemics
4-9-2021Cross-posted from NIAID NewsroomThe COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevent…
To End HIV Epidemic, We Must Address Health Disparities
2-19-2021For social media: NIH-funded researchers and others report on US efforts to end the #HIV epidemic in @TheLancet, calling for #HealthDisparities to be addressed.…
Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find
1-26-2021#HIVPrevention NEWS from @NIAIDnews: Infusions of an anti-HIV #antibody prevented acquisition of #HIV strains sensitive to that antibody, but did not significan…
NIH Announces Restructured HIV Clinical Trials Networks
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
NIH Study Finds Long-Acting Injectable Drug Prevents HIV Acquisition in Cisgender Women
11-9-2020Cross-posted from NIAID NewsroomLong-Acting Regimen More Effective than Daily Oral Pill Among African WomenA pre-exposure prophylaxis (PrEP) regimen containing …